Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +12.4%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (494)

clinicaltrialsPublishedShowing 151–200 of 627 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06069726	A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial(MOAB)	recruiting	Phase 2	80	Duke UniversityOTHER	1	Jul 31, 2026	clinicaltrials
NCT03970447	A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma(GBM AGILE)	recruiting	Phase 2 / Phase 3	2,250	Global Coalition for Adaptive ResearchOTHER	6